In Focus, December 2008

Article

All the latest news and industry developments in focus, December 2008

Please click on any of the headlines below to see the full story.

DR study: 25 year results
Although there is a relatively high rate of diabetic retinopathy (DR) progressing to proliferative diabetic retinopathy (PDR), the level of PDR care available has improved, according to 25-year results of the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), published in the November issue of Ophthalmology

ARVO to award young scientists
A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc. 

Regrowth of optic nerve cells achieved
It may be possible to regenerate optic neural axons by manipulating growth control pathways, according to study results published in the 7 November issue of the journal Science

Anti-VEGFs may cause blindness
Long-term use of anti-vascular endothelial growth factor (VEGF) drugs should be treated with caution because endogenous VEGF plays an important role in the maintenance of retina neuronal cells, according to study results published by PLoS ONE on the 3rd November. 

Treating paediatric convergence
Office-based vergence/accommodative therapy with home reinforcement (OBVAT) is the most effective method of treating symptomatic convergence insufficiency when compared with any other home- or office-based placebo or therapy, according to study results published in the October issue of the Archives of Ophthalmology

Night vision and AMD
Problems with night vision correlate to an increase in the risk of symptoms of both the wet and dry forms of age-related macular degeneration (AMD), according to study results published in the November issue ofOphthalmology

Blindness risk double in men
Despite the higher rate of prevalence in women, it is men who are more likely to suffer severe vision loss as a result of idiopathic intracranial hypertension (IIH), according to study results published online ahead of print by Neurology

 

For up-to-date news and announcements, please check the latest news section of our website. Alternatively, please sign up for our weekly newsletter.

Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Related Content
© 2025 MJH Life Sciences

All rights reserved.